Connect with us

INDUSTRIAL HEMP

Tetra Bio Pharma Inc (OTCQB:TBPMF) Anticipates To Commercialize ‘Dronabinol XL’ Tablet Ahead of Schedule In the U.S.

Published

on

Tetra Bio Pharma Inc (OTCQB:TBPMF) reported that it is associating with a key manufacturer of controlled APIs in the U.S. for the production of Dronabinol XL AdVersa® as the firm ramps up its plans to file a 505(b)(2) NDA for the treatment of CINV and anorexia related with weight loss in people with AIDS.

The details

As per a market research, the international chemotherapy-induced nausea and vomiting market will touch a valuation of $1.88 billion by 2020, up from its 2013 worth of $1.28 billion. Grounded on the projected enhanced safety profile of a DR Dronabinol, Tetra Bio project that the Adversa® tablet can record a notable share of this market within 3 years of its release in the United States, with sales of Adversa® that is projected to hit $30 million at the close of the third year of sales.

Earlier in March, Tetra got the Dronabinol XL Adversa® know-how from IntelGenx and finalized a co-development deal to get this controlled release formulation of tetrahydrocannabinol to the market. The company is seeking to boost its commercialization plans in the United States by seeking marketing nod by the Food and Drug Administration for the different therapeutic indications, which are similar to those of Marinol®.

Use in curing anorexia related with weight loss in people with AIDS, and vomiting and nausea associated with cancer chemotherapy in people who have failed to respond sufficiently to conventional antiemetic treatments. It’s buccal management in instances of nausea makes it a remarkable attractive therapeutic alternative for cancer patients.

Tetra’s association with a key manufacturer in the United States that has been producing dronabinol for years to advance the commercial manufacturing of this patent-protected new drug is important in its filing to the FDA. The NDA submission under 505(b)(2) to the U.S. FDA needs demonstration that the formulation offers similar systemic exposure to the approved/listed drug dronabinol.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized3 days ago

Top 15 Essential Oils + Health Benefits

Top 15 Essential Oils + Health Benefits Each and every essential oil contains compounds with unique healing and therapeutic benefits....

Uncategorized3 days ago

Using Hemp Oil in Cooking

Hemp oil has many advocates. The oil from hemp seeds is rich in omega-3 and omega-6 essential fatty acids. This makes...

Uncategorized1 week ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health3 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business3 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business3 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business3 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP3 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP3 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP3 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

Advertisement
Advertisement
Advertisement